SERENA: "Abolizione delle sanzioni per la scorretta vendita dei medicinali" (2053)

This procedure concerns the potential abolition of sanctions related to the incorrect sale of medicines. It aims to review and possibly remove penalties associated with how medicines are sold. This could affect pharmacies, pharmaceutical companies, and consumers by changing the regulatory framework and potential penalties for sales practices.